66 related articles for article (PubMed ID: 23042095)
1. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
2. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
[TBL] [Abstract][Full Text] [Related]
3. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.
Virani S; Bellile E; Bradford CR; Carey TE; Chepeha DB; Colacino JA; Helman JI; McHugh JB; Peterson LA; Sartor MA; Taylor JM; Walline HM; Wolf GT; Rozek LS
BMC Cancer; 2015 Oct; 15():825. PubMed ID: 26518708
[TBL] [Abstract][Full Text] [Related]
4. Serum biomarkers for detection of head and neck squamous cell carcinoma.
Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
[TBL] [Abstract][Full Text] [Related]
5. Head-Down Topical Sinus Rinses: Cut Your Way to Success.
Wu AW; Tang DM; Liu GC
Am J Rhinol Allergy; 2024 May; 38(3):192-193. PubMed ID: 38462932
[No Abstract] [Full Text] [Related]
6. Salivary biomarkers for oral cancer and pre-cancer screening: a review.
Kaur J; Jacobs R; Huang Y; Salvo N; Politis C
Clin Oral Investig; 2018 Mar; 22(2):633-640. PubMed ID: 29344805
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancers.
Aghiorghiesei O; Irimie AI; Braicu C; Raduly L; Nutu A; Balint E; Mehterov N; Vladimirov B; Sarafian V; Lucaciu O; Campian R; Berindan-Neagoe I
Med Pharm Rep; 2023 Jul; 96(3):310-317. PubMed ID: 37577021
[TBL] [Abstract][Full Text] [Related]
8. Using Liquid Biopsy to Predict Relapse After Radiotherapy in Squamous Cell Head-Neck and Esophageal Cancer.
Koukourakis IM; Xanthopoulou E; Koukourakis MI
Cancer Diagn Progn; 2023; 3(4):403-410. PubMed ID: 37405217
[TBL] [Abstract][Full Text] [Related]
9. Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer.
Birknerova N; Mancikova V; Paul ED; Matyasovsky J; Cekan P; Palicka V; Parova H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230805
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing-based salivary biomarkers in oral squamous cell carcinoma.
Sodnom-Ish B; Eo MY; Myoung H; Lee JH; Kim SM
J Korean Assoc Oral Maxillofac Surg; 2022 Feb; 48(1):3-12. PubMed ID: 35221302
[TBL] [Abstract][Full Text] [Related]
11. A 13-Gene DNA Methylation Analysis Using Oral Brushing Specimens as an Indicator of Oral Cancer Risk: A Descriptive Case Report.
Rossi R; Gissi DB; Gabusi A; Fabbri VP; Balbi T; Tarsitano A; Morandi L
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204376
[TBL] [Abstract][Full Text] [Related]
12. Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis.
Camuzi D; Simão TA; Dias F; Ribeiro Pinto LF; Soares-Lima SC
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830785
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid.
Gama RR; Arantes LMRB; Sorroche BP; De Marchi P; Melendez ME; Carvalho RS; de Lima MA; Vettore AL; Carvalho AL
Sci Rep; 2021 Aug; 11(1):16415. PubMed ID: 34385507
[TBL] [Abstract][Full Text] [Related]
14. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis.
Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Santos MA; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34206840
[TBL] [Abstract][Full Text] [Related]
15. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis.
Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Muinelo-Romay L; Muinelo-Lorenzo J; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204396
[TBL] [Abstract][Full Text] [Related]
16. Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer.
Rapado-González Ó; López-Cedrún JL; López-López R; Rodríguez-Ces AM; Suárez-Cunqueiro MM
J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33947071
[TBL] [Abstract][Full Text] [Related]
17. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
[TBL] [Abstract][Full Text] [Related]
18. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives.
Cristaldi M; Mauceri R; Di Fede O; Giuliana G; Campisi G; Panzarella V
Front Physiol; 2019; 10():1476. PubMed ID: 31920689
[TBL] [Abstract][Full Text] [Related]
19. 13-gene DNA Methylation Analysis from Oral Brushing: A Promising Non Invasive Tool in the Follow-up of Oral Cancer Patients.
Gissi DB; Tarsitano A; Gabusi A; Rossi R; Attardo G; Lenzi J; Marchetti C; Montebugnoli L; Foschini MP; Morandi L
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31810211
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
